These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23775046)

  • 1. The prevalence of glucose intolerance in Japanese schizophrenic patients with a normal fasting glucose level.
    Ono S; Suzuki Y; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Saito M; Someya T
    J Clin Psychopharmacol; 2013 Aug; 33(4):525-7. PubMed ID: 23775046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.
    Green FC; Levison R; Newton DJ; Littleford R; Stonebridge PA; Belch JJ
    Int Angiol; 2012 Apr; 31(2):125-8. PubMed ID: 22466976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of postpartum impaired glucose tolerance after gestational diabetes].
    Romero Gutiérrez G; Macias Rocha AL; Puente Alvarez EI
    Ginecol Obstet Mex; 2012 Oct; 80(10):631-6. PubMed ID: 23240225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.
    Ryan MC; Collins P; Thakore JH
    Am J Psychiatry; 2003 Feb; 160(2):284-9. PubMed ID: 12562574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke.
    Ivey FM; Ryan AS; Hafer-Macko CE; Garrity BM; Sorkin JD; Goldberg AP; Macko RF
    Cerebrovasc Dis; 2006; 22(5-6):368-71. PubMed ID: 16888377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
    Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
    Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of impaired glucose tolerance in hospitalized essential hypertension patients without diabetes mellitus history and with normal fasting glucose].
    Ren JY; Yu ZQ; Zhao D; Sun JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):134-7. PubMed ID: 19719989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of impaired glucose tolerance and diabetes mellitus in subjects with fasting blood glucose below 6.1 mmol/L (110 mg/dL).
    Khan SH; Ijaz A; Bokhari SA; Hanif MS; Azam N
    East Mediterr Health J; 2013 Feb; 19(2):175-80. PubMed ID: 23516829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
    Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
    Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia.
    Spelman LM; Walsh PI; Sharifi N; Collins P; Thakore JH
    Diabet Med; 2007 May; 24(5):481-5. PubMed ID: 17381506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study.
    Hirakawa Y; Ninomiya T; Mukai N; Doi Y; Hata J; Fukuhara M; Iwase M; Kitazono T; Kiyohara Y
    Am J Epidemiol; 2012 Nov; 176(10):856-64. PubMed ID: 23100249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysglycaemia in vascular surgery patients.
    Astor M; Søfteland E; Daryapeyma A; Jonung T
    Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):447-51. PubMed ID: 20149695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two risk score models for predicting incident Type 2 diabetes in Japan.
    Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Iwase M; Kiyohara Y
    Diabet Med; 2012 Jan; 29(1):107-14. PubMed ID: 21718358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.